IBEX (NASDAQ:IBEX) Stock: Insider Christina Al Trofimuk-O’connor Sells 1,000 Shares

Posted by Brenda Bartman on Nov 12th, 2026

IBEX Limited (NASDAQ:IBEX – Get Free Report) insider Christina O’Connor sold 1,000 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $51.46, for a total transaction of $51,460.00. Following the sale, the insider owned 37,424 shares of the company’s stock, valued at approximately $1,925,839.04. This represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Christina Al Trofimuk-O’connor also recently made the following trade(s):

On Wednesday, September 16th, Christina O’Connor sold 2,376 shares of IBEX stock. The shares were sold at an average price of $39.34, for a total transaction of $93,471.84.
On Tuesday, September 15th, Christina O’Connor sold 7,500 shares of IBEX stock. The shares were sold at an average price of $40.30, for a total transaction of $302,250.00.

IBEX Stock Performance

Shares of IBEX opened at $55.32 on Thursday. IBEX Limited has a fifty-two week low of $25.94 and a fifty-two week high of $55.77. The company has a market capitalization of $737.64 million, a price-to-earnings ratio of 16.76 and a beta of 0.74. The firm has a 50-day simple moving average of $43.86 and a 200-day simple moving average of $34.72.

IBEX (NASDAQ:IBEX – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.20. The firm had revenue of $175.23 million for the quarter, compared to analyst estimates of $169.31 million. IBEX had a return on equity of 29.10% and a net margin of 7.34%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Ieq Capital LLC lifted its position in shares of IBEX by 11.8% during the 3rd quarter. Ieq Capital LLC now owns 14,638 shares of the company’s stock valued at $633,000 after acquiring an additional 1,545 shares during the period. Boston Partners grew its holdings in shares of IBEX by 15.3% in the 3rd quarter. Boston Partners now owns 397,353 shares of the company’s stock worth $17,189,000 after acquiring an additional 52,638 shares during the period. Virtus Advisers LLC grew its holdings in shares of IBEX by 18.9% in the 3rd quarter. Virtus Advisers LLC now owns 22,920 shares of the company’s stock worth $992,000 after acquiring an additional 3,645 shares during the period. Russell Investments Group Ltd. grew its holdings in shares of IBEX by 370.5% in the 3rd quarter. Russell Investments Group Ltd. now owns 14,361 shares of the company’s stock worth $623,000 after acquiring an additional 11,309 shares during the period. Finally, Ritholtz Wealth Management grew its holdings in shares of IBEX by 10.0% in the 3rd quarter. Ritholtz Wealth Management now owns 60,230 shares of the company’s stock worth $2,606,000 after acquiring an additional 5,480 shares during the period. 81.24% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Weiss Ratings upgraded IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, October 12th. Wall Street Zen raised IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 7th. Royal Bank Of Canada upped their price target on IBEX from $40.00 to $45.00 and gave the stock a “sector perform” rating in a research note on Tuesday. Finally, Robert W. Baird upped their price target on IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Monday, September 28th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $44.50.

Get Our Latest Report on IBEX

IBEX News Roundup

These are some of the IBEX news items that stood out recently:

Positive Sentiment: Recent earnings beat: The latest reported quarter exceeded analyst estimates for both earnings and revenue, providing a positive fundamental backdrop for the stock.
Neutral Sentiment: Investor conference: CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC Global TIMT Conference on November 17. The appearance may give investors more insight into the business, but no new guidance was announced. Conference announcement
Negative Sentiment: Multiple insiders sold shares: Six insiders, including CEO Dechant, sold about 31,200 shares in transactions reported around November 9–10. Dechant’s sale was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares, but the cluster of sales may weigh on sentiment. CEO filing Insider sale report

About IBEX

(Get Free Report)

IBEX Limited is a business process outsourcing and customer experience company that helps businesses manage interactions with their customers. Its services include customer acquisition, customer care, technical support, back-office operations and digital solutions. The company serves clients across industries such as technology, telecommunications, retail, healthcare and financial services. IBEX delivers its services through a global network of contact centers and digital operations, supporting customers in multiple markets.